Most people meet AI video the same way. They type a sentence, wait a moment, and a clip appears that looks oddly close to ...

During a House Oversight Committee hearing titled "Amnesty and Chaos: Abuse of U.S. Immigration Policy," Representative James Walkinshaw (D-VA) gave his Republican colleagues an example of "chaos" by ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Prime Video's got a small selection of Original titles heading to the ...

Join the Tom's Guide Club for quick access. Enter your email below and we'll send confirmation, and sign you up to our newsletter.

The first Minecraft 26.2 pre-release is here for Java Edition, but there's some bad news if you've been taking advantage of the sandbox game's new peer-to-peer multiplayer, which was implemented in a ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 10 Best Penny Stocks to Buy for Long Term. On May 14, 2026, Morgan Stanley raised the firm’s price target on Recursion Pharmaceuticals, Inc.

In a rare direct address, Secretary of State Marco Rubio blamed the former leader Raúl Castro for the country’s longstanding electricity and resource shortages. By Ali Watkins Secretary of State Marco ...

Google is giving the Gemini app a massive update, bringing a bunch of nifty changes. The chatbot phase is fading, and the company now wants Gemini to become something closer to a full-time digital ...

Deepfake versions of Mick Jagger, Keith Richards, and Ronnie Wood – all looking like they did about half a century ago – sing their latest single “In the Stars” in a new video for the song directed by ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...

Recursion Pharmaceuticals (RXRX Quick Quote RXRX - Free Report) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.5 ...